All News

Hyperbaric oxygen therapy in a randomized placebo-controlled trial resulted in improved global cognitive function, energy, sleep, and pain interference in long COVID patients.

Your daily dose of clinical news you may have missed.

The FDA wants clinicians to avoid using the neutralizing antibody as it appears to be less effective against newer circulating strains of the SARS-CoV-2 virus.

The DASH diet, Mediterranean diet, and Flexitarian diet top the list of 10 best diets for persons with diabetes as ranked by US News and World Report.

A pivotal study with 40-year follow-up of post-bariatric surgery patients reinforces long-term benefits of the procedures on all-cause and cause-specific mortality.

Mental health issues among health care professionals have always been normal; now that we can acknowledge them, we must, says a family physician and wellness advocate.

Results from longitudinal prospective cohort study underscore the importance of monitoring patients’ weight throughout adulthood to reduce the risk of frailty.

AAFP president Tochi Iroku-Malize, MD, MPH, MBA, urges gentle but persistent efforts among all clinicians to get school-aged children back on vaccination track.

The Kaiser Family Foundation survey found a 10% drop in the proportion of adults who say MMR vaccination should be required for school attendance, and other "halo" effects.

Preliminary estimates showed relative bivalent booster dose vaccine effectiveness against XBB/XBB.1.5 for at least the first 3 months after vaccination.

Accelerometer-measured physical activity and steps were associated with as much as a 60% lower risk of Alzheimer's disease and related dementias in a new study.

Tochi Iroku-Malize, MD, MPH, MBA, converts the 93% immunization rate for US kindergarteners into raw numbers of children now vulnerable to vaccine-preventable disease.

Your daily dose of clinical news you may have missed.

New research offers insight into how women who use cannabis during pregnancy perceive the impacts of cannabis legalization.

Sustained weight loss with semaglutide 2.4 mg is a result of the drug's effects on control of eating, including reduced cravings and hunger and increased satiety, study authors write.

Your daily dose of clinical news you may have missed.

Bexagliflozin significantly improved glycemic control in adults when used as monotherapy, in combination with metformin, or when added to several SOC regimens.

Adults with T2D may be able to reduce their liver fat and improve their liver fibrosis stage with reductions in HbA1c, according to findings from a retrospective analysis.